Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Panic Over FDA Commissioner's Resignation Was Short-Lived, Though IPOs Still Languish

Mar 18 2019

• By Mandy Jackson

Finance Watch

Related Content

Opioid Litigation: Drug Mfrs. Lose Bid To Limit Data Disclosure; First Trials Set For March

Jul 04 2018

New Acting US FDA Commissioner Shares Agency's Clinical Trial Reform Message

Mar 13 2019

Keeping Track: Two Goal Date Extensions, Another Herceptin Biosimilar Approval, And A BLA Withdrawal

Mar 15 2019

Finance Watch: With The Year's Biggest IPO, CFO Says Allogene Is Ready To Go 'Full Throttle'

Oct 12 2018

BioNTech Raises $270M Series A Round To Pursue FIPCO Model

Jan 04 2018

Deal Watch: Bristol Leaves Neuropathic Pain Candidate To Lexicon

Nov 09 2016

IPO Update: Returns Run Red For Most Biopharma Firms That Went Public In The US Last Year

Jan 04 2019

Sanofi Takes €80M BioNTech Stake & Extends 2015 Deal

Jan 04 2019

Finance Watch: Bitcoin For Biopharma? Agenus Gives BEST A Shot

Jan 31 2019

Finance Watch: Genocea, Mateon Shift Strategies, Cut Jobs To Preserve Cash

Sep 28 2017

With Jeuveau Approval, Evolus Will Focus On The Beauty Business To Gain Market Share

Feb 05 2019

Axovant Closes Chapter On Failed, Second-Rate Small Molecule Strategy

Dec 11 2018

In NASH Race, Bad News For Conatus, Good News For Genfit In PBC

Dec 10 2018

Verastem’s Copiktra Gets Early Approval To Challenge Zydelig, Venclexta In Third-Line CLL

Sep 25 2018

Finance Watch: In Obesity, Vivus Raises Cash For Deals, Orexigen Finds A Buyer

May 03 2018

Interview: BioNTech And Pfizer Explore mRNA Flu Vaccines In $120m+ Deal

Aug 16 2018

Gottlieb: Epidiolex Approval Covers One Specific Cannabidiol Medication, Not Marijuana

Jun 25 2018

Gottlieb's Short Tenure Will Be Felt Long After He Leaves US FDA

Mar 06 2019

Horizon Pharma Sees Mid-2019 BLA For Tepro After Solid Phase III TED Data

Mar 01 2019

Related Companies

Precision BioSciences, Inc.

Poseida Therapeutics, Inc.

Genfit SA

BioNTech SE

Moderna, Inc.

Pfizer Inc.

Sanofi

Biohaven Pharmaceutical Holding Company Ltd.

GW Pharmaceuticals plc

Allergan plc

Endo, Inc.

Ascendis Pharma A/S

Sarepta Therapeutics, Inc.

Myonexus Therapeutics, Inc.

Horizon Therapeutics plc

Epizyme, Inc.

Apellis Pharmaceuticals, Inc.

Evolus, Inc.

Sio Gene Therapies, Inc.

Roivant Sciences Ltd.

Matinas BioPharma Holdings, Inc.

Infinity Pharmaceuticals, Inc.

Verastem, Inc.

Agenus Inc.

Additional Topics

Deals Financing Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.